CDKN1B and breast cancer: Evidence has shown that miR‐222‐3p could target several genes, and a relationship of miR‐222‐3p‐targeted CDKN1B has been implicated in breast cancer cells 29 and vascular smooth muscle cells 30, but this relationship has not been reported in NP cells.